Download PDF
Semin Liver Dis 2009; 29(1): 134-138
DOI: 10.1055/s-0029-1202551
DIAGNOSTIC PROBLEMS IN HEPATOLOGY

© Thieme Medical Publishers

Chronic Rejection Preceded by Central Perivenulitis, Rapidly Ensuing After Liver Transplantation in a Pediatric Patient

Tamir Miloh1 , Margret S. Magid2 , Kishore Iyer3 , Nanda Kerkar1 , Raffaella A. Morotti2
  • 1Department of Pediatrics, Mount Sinai School of Medicine, New York, New York
  • 2The Lillian and Henry Stratton-Hans Popper Department of Pathology, Mount Sinai School of Medicine, New York, New York
  • 3The Recanati-Miller Transplant Institute, Mount Sinai School of Medicine, New York, New York
Further Information

Publication History

Publication Date:
23 February 2009 (online)

    Permissions and Reprints

ABSTRACT

A 15-year-old boy who underwent liver transplantation for fulminant Wilson's disease, presented with elevated transaminases 2 months post-transplant. He had recently seroconverted from previous Epstein-Barr virus (EBV) naive status and by polymerase chain reaction (PCR) had increasing viral load copies of EBV in blood. A liver biopsy was obtained 6 weeks post-transplant, which showed isolated central perivenulitis (CP). His immunosuppresion was reduced and antiviral therapy was added with subsequent increase in liver transaminases. A second liver biopsy 6 weeks later again showed isolated CP. Subsequent further reduction in immunosuppression was followed by the appearance of portal-based moderate acute cellular rejection that was resistant to immunosuppressive treatment and rapidly evolved into ductopenic chronic rejection. This case report underlines the difficulties in interpreting isolated perivenulitis, especially in the setting of EBV seroconversion, and suggests that it may not only represent a form of acute rejection but also a predictor of rapidly progressing chronic rejection.

KEYWORDS

Isolated central perivenulitis - liver transplantation - pediatric - chronic rejection - EBV hepatitis

REFERENCES

  • 1 Ben-Ari Z, Amlot P, Lachmanan S R et al.. Postransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.  Liver Transpl Surg. 1999;  5 184-191
    CrossrefPubMedSearch in Google Scholar
  • 2 Holmes R D, Orban-Eller K, Karrer F R et al.. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome.  Transplantation. 2002;  74 367-372
    CrossrefPubMedSearch in Google Scholar
  • 3 Lee T C, Savoldo B, Rooney C M et al.. Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.  Am J Transplant. 2005;  5 2222-2228
    CrossrefPubMedSearch in Google Scholar
  • 4 Jang J Y, Kim K M, Lee Y J et al.. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation.  Transplant Proc. 2008;  40 2546-2548
    CrossrefPubMedSearch in Google Scholar
  • 5 Kogan D L, Burroughs M, Emre S et al.. Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients.  Transplantation. 1999;  67 1068-1070
    CrossrefPubMedSearch in Google Scholar
  • 6 Muiesan P, Vergani D, Mieli-Vergani G. Liver transplantation in children.  J Hepatol. 2007;  46 340-348
    CrossrefPubMedSearch in Google Scholar
  • 7 Ng V, Anand R, Martz K, Fecteau A. Liver retransplantation in children: a SPLIT database analysis of outcome and predictive factors for survival.  Am J Transplant. 2008;  8 386-395
    PubMedSearch in Google Scholar
  • 8 Shepherd R W, Turmelle Y, Nadler M et al.. Risk factors for rejection and infection in pediatric liver transplantation.  Am J Transplant. 2008;  8 396-403
    CrossrefPubMedSearch in Google Scholar
  • 9 Demetris A J, Adeyi O, Bellamy C O et al.. Liver biopsy interpretation for causes of late liver allograft dysfunction.  Hepatology. 2006;  44 489-501
    CrossrefPubMedSearch in Google Scholar
  • 10 Demetris A J. Central venulitis in liver allografts: considerations of differential diagnosis.  Hepatology. 2001;  33 1329-1330
    CrossrefPubMedSearch in Google Scholar
  • 11 Krasinskas A M, Demetris A J, Poterucha J J, Abraham S C. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers.  Liver Transpl. 2008;  14 625-632
    CrossrefPubMedSearch in Google Scholar
  • 12 Banff schema for grading liver allograft rejection: an international consensus document.  Hepatology. 1997;  25 658-663
    CrossrefPubMedSearch in Google Scholar
  • 13 Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation.  J Hepatol. 2004;  40 3-7
    PubMedSearch in Google Scholar
  • 14 Demetris A, Adams D, Bellamy C et al.. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection.  Hepatology. 2000;  31 792-799
    CrossrefPubMedSearch in Google Scholar
  • 15 Neil D A, Hubscher S G. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts.  Hepatology. 2002;  35 639-651
    CrossrefPubMedSearch in Google Scholar
  • 16 D'Antiga L, Dhawan A, Portmann B et al.. Late cellular rejection in paediatric liver transplantation: aetiology and outcome.  Transplantation. 2002;  73 80-84
    PubMedSearch in Google Scholar
  • 17 Abraham S C, Freese D K, Ishitani M B et al.. Significance of central perivenulitis in pediatric liver transplantation.  Am J Surg Pathol. 2008;  32 1479-1488
    CrossrefPubMedSearch in Google Scholar

Raffaella MorottiM.D. 

Department of Pathology, Box 1194, Mount Sinai School of Medicine

One Gustave L. Levy Place, New York, NY 10029

Email: Raffaella.Morotti@msnyuhealth.org